Hello,

Is anyone aware of a protect from light bag that is clear? We've received outsourced products that are in clear bags labeled as UV/light protected, but can't have any luck finding this same type of product for our own use.

Thanks,
Pam
UPMC
Pittsburgh, PA

Hello All,

I would like to inquire about insulin intravenous infusion concentration(s) that you are using at your facilities for diabetic ketoacidosis management in pediatrics. We had a discussion at our organization about utilizing the ASHP Standardize 4 Safety Proposed Standard Concentrations for Pediatric IV Continuous infusion which calls for 0.05, 0.2, and 1 unit/mL.

Question: How have hospitals worked around possible HIPAA violation issues when using the Patient ID function on smart pumps?

Background: We recently pursued a path to require RNs to enter the MR# in the Patient ID on our smart pumps (Alaris), but were stopped due to a concern over a possible HIPAA violation should a smart pump "go missing" (leave the hospital).

Other facilities who have interoperability (bidirectional communication between eMAR and the smart pump) would theoretically have the same issue.

Hi all,

We are looking to implement appropriate safeguards for storage, dispensing, and administration of Myxredlin (insulin infusion). We are concerned with packaging and the risk of mix-ups with other bags which look similar--ISMP has already reported an actual error where insulin infusion run instead of cefazolin.

Can you share your practices for safeguards around following:

Can you share with me if you are using continuous pulse oximetry or capnography to monitor for opioid sedation in patients at greater risk, specifically asking for those areas outside of the critical care space.

Also, have you implemented the Michigan Opioid Safety Score (MOSS) or any other proactive screening tools to assess patients at greater risk for opioid sedation? Can you share which tool you are using?

Hello,
The FDA recently released a Medwatch alert on serious breathing problems for patients taking gabapentin or pregabalin and other CNS depressants. Also there's been more articles regarding misuse of gabapentin and baclofen (https://www.tandfonline.com/doi/pdf/10.1080/15563650.2019.1687902?needAc...), especially with the initiatives to reduce opioid use and increase use of other pain medications.

I’d like to know which of the narcotics and controlled medications are allowed to be in the ward and the ER? Is there a specific list or a policy?
Thank you

Wondering if anyone has strategies for handling situations where NIOSH table 1 oral medications need to be given via routes other than Oral, i.e. NG/OG/JT. Seems like USP 800 does not allow manipulation of a tablet or capsule outside of a CACI/BSC/powder hood?

hello,

I need updated list of medication do not tube, and if any one have information about transferring sterile preparation via pneumatic tube.

thank you,